Results for: Counterfeit Injections

The Centers for Disease Control and Prevention (CDC) issued an advisory on the risks of counterfeit or mishandled Botox injections after reports of harmful reactions in multiple states. The CDC, FDA, and local health departments are investigating clusters of 22 women who experienced adverse effects, including blurred vision, drooping eyelids, and shortness of breath, after receiving Botox injections. The incidents are linked to unlicensed or untrained providers and injections in non-healthcare settings. Counterfeit Botox products may have lot number C3709C3 and display the active ingredient as “Botulinum Toxin Type A” instead of “OnabotulinumtoxinA”. Clinicians are urged to consider the possibility of adverse effects from botulinum toxin injections and contact health departments if suspected. Botox should be administered only by licensed providers using FDA-approved doses and in healthcare settings.

Health officials have issued a warning about the dangers of illegitimate Botox injections following a surge in hospitalizations due to harmful reactions. These reactions are reportedly linked to counterfeit material or untrained injection practices. Several cases have been reported in the US, with three individuals in New York receiving emergency treatment for symptoms such as double vision, drooping eyelids, and difficulty breathing. Experts attribute the rise in adverse reactions to the growing popularity of Botox parties and non-healthcare clinic settings.